Health
Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication – News-Medical.Net
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
The devastating impact of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to significant efforts to curb its transmission. When RNA viruses, like the SARS-CoV-2, replicate there could be versions of the virus that have large deletions in the viral genome,…
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Noosa News17 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts